Galina Velikova, BMBS, RCP, PhD, University of Leeds, UK, discusses the phase III eRAPID (electronic patient self-Reporting of Adverse-events: Patient Information and advice) study – an eHealth intervention study. eRAPID is an online system for patients to report symptoms during chemotherapy, providing automated severity-dependent advice (self-management or alerts for hospital contact). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology),